Pfizer (PFE) Intangibles (2009 - 2026)

Pfizer (PFE) has 18 years of Intangibles data on file, last reported at $52.6 billion in Q1 2026.

• Quarterly Intangibles fell 2.63% year-over-year to $52.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.6 billion (down 2.63% YoY) and the FY2025 annual result came in at $53.7 billion, down 3.03% from the prior year.
• Intangibles retreated to $52.6 billion in Q1 2026 per PFE's latest filing, from $53.7 billion in the prior quarter.
• Across five years, Intangibles topped out at $64.9 billion in Q4 2023 and bottomed at $28.2 billion in Q4 2022.
• The 5-year median for Intangibles is $52.6 billion (2026), against an average of $48.4 billion.
• The widest annual swing landed in 2022, when Intangibles surged 72.47%; it then slipped 14.62% in 2024.
• Tracing PFE's Intangibles over 5 years: stood at $43.4 billion in 2022, then surged by 49.64% to $64.9 billion in 2023, then retreated by 14.62% to $55.4 billion in 2024, then declined by 3.03% to $53.7 billion in 2025, then dropped by 2.18% to $52.6 billion in 2026.
• Per Business Quant, the three latest PFE Intangibles figures stand at $52.6 billion (Q1 2026), $53.7 billion (Q4 2025), and $51.3 billion (Q3 2025).

Peer Comparison